Medical Technology

@xconomy.com 3 years ago

Two Days, Six IPOs, and $1B Raised for Biotech Research & More

@xconomy.com 4 years ago

CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”

@xconomy.com 4 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 4 years ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

@xconomy.com 4 years ago

New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)